Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
31.3M
-
Shares change
-
-251K
-
Total reported value, excl. options
-
$129M
-
Value change
-
-$2.25M
-
Number of buys
-
43
-
Number of sells
-
-38
-
Price
-
$4.12
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q3 2018
102 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q3 2018.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.3M shares
of 52.3M outstanding shares and own 59.91% of the company stock.
Largest 10 shareholders include Evermore Global Advisors, LLC (4.56M shares), BlackRock Inc. (3.99M shares), WELLINGTON MANAGEMENT GROUP LLP (3.86M shares), RENAISSANCE TECHNOLOGIES LLC (2.96M shares), Vanguard Group Inc (2.72M shares), DIMENSIONAL FUND ADVISORS LP (2.04M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.98M shares), Roumell Asset Management, LLC (765K shares), STATE STREET CORP (761K shares), and NORTHERN TRUST CORP (572K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.